SCHEMBL13868624

SCHEMBL13868624

COC(=O)c1cc2ccc(N(C)C)cc2c2c1C=CC(c1ccccc1)(c1ccccc1)O2

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 5/20 0.35
ALDH1A1 P00352 5/20 0.35
HPGD P15428 3/20 0.35
NPSR1 Q6W5P4 2/20 0.35
GABRA1 P14867 1/20 0.35
GABRG2 P18507 1/20 0.35
GABRB3 P28472 1/20 0.35
GABRA3 P34903 1/20 0.35
GABRA2 P47869 1/20 0.35
MAPT P10636 4/20 0.34
MEN1 O00255 1/20 0.34
KMT2A Q03164 1/20 0.34
SLC16A3 O15427 1/20 0.34
GPR84 Q9NQS5 2/20 0.33
HSD17B10 Q99714 1/20 0.33
SLC6A2 P23975 1/20 0.33
SLC6A4 P31645 1/20 0.33
SLC6A3 Q01959 1/20 0.33
MPL P40238 1/20 0.32
ROCK2 O75116 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7488070 0.94 ALDH1A1 (0.33) KDM4EALDH1A1HPGDNPSR1GABRA1
SCHEMBL9912591 0.91 ALDH1A1 (0.39) KDM4EALDH1A1HPGDNPSR1GABRA1
SCHEMBL1847688 0.90 GABRG2 (0.37) KDM4EALDH1A1HPGDNPSR1GABRG2
SCHEMBL7473791 0.90 NPC1 (0.33) ALDH1A1HPGDGABRA1GABRG2GABRB3
SCHEMBL5650444 0.89 MAPT (0.38) KDM4EALDH1A1MAPTMEN1KMT2A
SCHEMBL891063 0.89 LRP6 (0.33) KDM4EALDH1A1NPSR1GABRA1GABRG2
SCHEMBL31148988 0.86 KDM4E (0.32) KDM4EALDH1A1HPGDMAPTHSD17B10
SCHEMBL26290022 0.86 KDM4E (0.45) KDM4EALDH1A1HPGDNPSR1MAPT
SCHEMBL30561944 0.85 NTSR1 (0.33) KDM4ENPSR1MAPTMEN1KMT2A
SCHEMBL29236269 0.85 NTSR1 (0.33) KDM4ENPSR1MAPTMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7521004-B2 Chromene compound TOKUYAMA CORPORATION (JP) 2009-04-21 US disclosed
US-7521004-B2 Chromene compound TOKUYAMA CORPORATION (JP) 2009-04-21 US disclosed
EP-1674460-B1 CHROMENE COMPOUND TOKUYAMA CORP (JP) 2009-01-21 EP disclosed
US-20070215844-A1 Chromene Compound TOKUYAMA CORPORATION (JP) 2007-09-20 US disclosed
US-20070215844-A1 Chromene Compound TOKUYAMA CORPORATION (JP) 2007-09-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070215844-A1 Chromene Compound CRY2, TYR, CRY1 KDM4E 1354/4885ALDH1A1 2110/4885HPGD 1369/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.